Nexgel (NXGLW) Capital Leases (2024 - 2025)
Nexgel (NXGLW) reported Capital Leases of $242000.0 for Q4 2025, down 21.17% on a YoY basis from $307000.0 in Q4 2024, and down 6.56% quarter-over-quarter from $259000.0 in Q3 2025.
Nexgel (NXGLW) Capital Leases (2024 - 2025) Analysis & Trends
Nexgel has reported Capital Leases for 2 years, with the latest figure at $242000.0 in Q4 2025.
- For the quarter ending Q4 2025, Capital Leases fell 21.17% year-over-year to $242000.0; the trailing twelve-month figure through Dec 2025 stood at $242000.0 (down 21.17% YoY), and the FY2025 full-year result was $242000.0, down 21.17% from the prior year.
- Capital Leases for Q4 2025 stood at $242000.0, down from $259000.0 in the prior quarter.
- The five-year high for Capital Leases was $352000.0 in Q1 2024, with the low at $242000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Nexgel | - | - | 819,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 242,000.00 |
| Sep 30, 2025 | 259,000.00 |
| Jun 30, 2025 | 275,000.00 |
| Mar 31, 2025 | 293,000.00 |
| Dec 31, 2024 | 307,000.00 |
| Sep 30, 2024 | 323,000.00 |
| Jun 30, 2024 | 339,000.00 |
| Mar 31, 2024 | 352,000.00 |